Gabriele Pecher

Hessische Str. 3-4
Mitte, BE 10115, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Chimeric Antigen Receptor (CAR)-NK92 cells effective against glioblastoma, breast- and pancreatic cancer in vitro and in a murine xenograft model of ovarian cancer.

Chimeric Antigen Receptor (CAR)-NK92 cells effective against glioblastoma, breast- and pancreatic cancer in vitro and in a murine xenograft model of ovarian cancer.

Journal: Cancer cell international

Published: December 10, 2024

Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer.

Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer.

Journal: Cancers

Published: December 04, 2023

Role of beta-(1→3)(1→6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D cultures.

Role of beta-(1→3)(1→6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D cultures.

Journal: BMC cancer

Published: August 25, 2023

Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer.

Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer.

Journal: International journal of molecular sciences

Published: March 28, 2023

Implications for Immunotherapy of Breast Cancer by Understanding the Microenvironment of a Solid Tumor.

Implications for Immunotherapy of Breast Cancer by Understanding the Microenvironment of a Solid Tumor.

Journal: Cancers

Published: April 11, 2022

HCMV-Mediated Interference of Bortezomib-Induced Apoptosis in Colon Carcinoma Cell Line Caco-2.

HCMV-Mediated Interference of Bortezomib-Induced Apoptosis in Colon Carcinoma Cell Line Caco-2.

Journal: Viruses

Published: December 17, 2020

Engineering NK Cells for CAR Therapy-Recent Advances in Gene Transfer Methodology.

Engineering NK Cells for CAR Therapy-Recent Advances in Gene Transfer Methodology.

Journal: Frontiers in immunology

Published: September 28, 2020

Efficacy and toxicity of docetaxel combination chemotherapy for advanced squamous cell cancer of the head and neck.

Efficacy and toxicity of docetaxel combination chemotherapy for advanced squamous cell cancer of the head and neck.

Journal: Molecular and clinical oncology

Published: February 03, 2017

Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic Colorectal Cancers.

Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic Colorectal Cancers.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 11, 2017

Pattern of the epitope-specific IgG/IgM response against human cytomegalovirus in patients with multiple myeloma.

Pattern of the epitope-specific IgG/IgM response against human cytomegalovirus in patients with multiple myeloma.

Journal: Clinical and vaccine immunology : CVI

Published: June 21, 2013

Yeast-derived beta-(1-3),(1-6)-D-glucan induces up-regulation of CD86 on dectin-1-positive human B-lymphoma cell lines.

Yeast-derived beta-(1-3),(1-6)-D-glucan induces up-regulation of CD86 on dectin-1-positive human B-lymphoma cell lines.

Journal: Anticancer research

Published: December 27, 2011

Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial.

Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial.

Journal: Cancer immunology, immunotherapy : CII

Published: May 09, 2002

Showing 1-12 of 13

Last Updated: 09/26/2026